Navigation Links
SAFC(R) & Cherokee Pharmaceuticals(TM) Pool Expertise and Resources With Strategic Partnership For U.S. Market

Collaboration Delivers Cost and Quality Benefits for Widespread cGMP Distribution

ST. LOUIS and PHILADELPHIA, June 1 /PRNewswire-FirstCall/ -- SAFC(R) (, a member of the Sigma-Aldrich(R) group (Nasdaq: SIAL) and Cherokee Pharmaceuticals(TM) (, a PRWT Services, Inc. company and minority owned business, today announced an exclusive strategic partnership that encompasses the sourcing, analytical testing, warehousing, packaging and distribution of large-scale raw materials for pharmaceutical manufacturing meeting cGMP quality standards.

The collaboration to co-market and co-sell raw materials for pharmaceutical customers will draw upon SAFC's global sourcing and production capabilities and combine these with Cherokee's world-class analytical laboratories, large-scale cGMP manufacturing, warehousing and distribution facilities. Under the agreement, SAFC will be responsible for all product sourcing including processing reagents and excipients from its network of over 10,000 active suppliers while Cherokee Pharmaceuticals will conduct analytical testing, storage, packaging and distribution services.

Located in Riverside, PA, Cherokee Pharmaceuticals features significant storage and expansion capabilities and has its own dedicated rail link to potentially serve the Northeast United States corridor where many of the world's leading pharmaceutical companies are located. SAFC will utilize Cherokee's fully cGMP validated site, which can house cooled, frozen and hazardous substances and serve as a key East Coast analytical, warehousing and distribution hub for large-scale raw materials towards the pharmaceutical industry.

Commenting on the strategic partnership Gilles Cottier, President of SAFC said: "This agreement is a win-win situation, not only for SAFC and Cherokee Pharmaceuticals, but also for our respective customers. In marrying SAFC's sourcing capabilities, which bring significant cost and quality benefits to the table, with Cherokee Pharmaceuticals expertise in analytical testing and cGMP manufacture and storage, we are providing top level, high-quality resourcing that will support our US customers throughout their respective supply chains, enabling them to both streamline and improve their risk mitigation strategies."

Murvin Lackey, President of Distribution for Cherokee Pharmaceuticals added, "The core competencies of both companies present a competitive advantage for us and our customers. This strategic partnership allows us to provide an integrated sourcing, distribution process to our customers who seek a secure supply chain."

About SAFC: SAFC(R) is the custom manufacturing and services group within Sigma-Aldrich that focuses on high-purity inorganics for high technology applications, cell culture products and services for biopharmaceutical manufacturing, biochemical production and the manufacturing of complex, multi-step organic synthesis of APIs and key intermediates. SAFC has manufacturing facilities around the world dedicated to providing manufacturing services for companies requiring a reliable partner to produce their custom manufactured materials. SAFC has four business segments - SAFC Pharma(R), SAFC Supply Solutions(R), SAFC Biosciences(R), and SAFC Hitech(R)- and had annual sales of over $600 million in 2008. SAFC is considered a top 10 fine chemical company. For more information about SAFC, visit

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 37 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at

About Cherokee Pharmaceuticals: Cherokee Pharmaceuticals, a PRWT Services, Inc. company, is a bulk chemical manufacturing and distribution company producing active pharmaceutical ingredients (APIs). Cherokee is the country's only minority-owned outsourced API provider. With a highly skilled workforce, cGMP facilities, and a 59-year history in fine chemical manufacturing, Cherokee Pharmaceuticals offers high-quality U.S. based manufacturing at a competitive cost. It has specialized skills in handling antibiotics, high hazard reactions and potent compounds. Cherokee Pharmaceuticals' APIs are used in several antibiotics for human and animal health, as well as in new compounds for cholesterol management and HIV treatment

SAFC(R), SAFC Supply Solutions(R) and Sigma-Aldrich(R) are registered trademarks of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co.

Cherokee Pharmaceuticals (TM) is a trademark of PRWT Services Inc.

SOURCE Sigma-Aldrich Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SAFC(R) Underlines Commitment to Pharmaceutical Supply Chain Quality With New Global Vendor Audit Services
2. National Cherokee Inspired Comfort Award Winners Announced
3. Cherokee Health Tee Proceeds Benefit Breast Cancer Research
4. Cherokee Inspired Comfort Awards Program Call for Nominations
5. Cherokee Inspired Comfort Awards Program Call for Nominations
6. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
7. Euro RSCG Life Broadens X2 Expertise
8. Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations
9. Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise
10. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
11. Customer Communications Group Selected by The Childrens Hospital for Direct Marketing Expertise
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, ... again for its stellar workplace culture with the company’s Cincinnati office being named ... Solutions’ Cincinnati office was named a finalist in Cincinnati Business Courier’s 13th annual ...
(Date:11/25/2015)... ... , ... Ministers, senior government and UN agencies, representatives from ... Excellence, and public R&D institutions, civil societies and other partners gathered today at ... Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day meeting ...
(Date:11/25/2015)... Los Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... advanced da Vinci surgical robot is being more and more widely heralded as a ... robotic assisted da Vinci method has over traditional laparoscopic surgery is that it can ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials of ... Narconon network, announced the release of a new cutting edge recovery program that has ... been working with drug- and alcohol-addicted individuals with the purpose to free addicts from ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy ... personal heating products business. Cozy Products explains what this means for business moving ... well with the Cozy Products business model: to sell personal heaters that reduce energy ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda SyMRI ... (MR-bilder) för patienter med multipel skleros ... forskningsavtal med SyntheticMR AB för att kunna ... på sjukhuset. Med SyMRI kan man generera ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology: